Serum vitamin B12 levels and some biochemical markers in Iraqi females with subclinical hypothyroidism
Abstract
Subclinical hypothyroidism (SCH) is characterized by increased conce n t r ation of thyroid-stimulating hormone (TSH) levels, while thyroid hormones (free thyroxine (T 4 ) and free triiodothyronine (T 3 )) conce n t r ation remain s within the reference ranges. D eficiency in vitamin B 12 is common in patients with autoimmune diseases, including the thyroid disorder autoimmune hypoth y roidism. Low level s of vitamin B 12 are reported in patients with hypothyroidism but with varied prevalence. Thus routine scree n ing, and early detection of vitamin B 12 level c an be helpful in prevent ing the further progression of sub c linical hypothyroidism. The aim of the present study is to detect the prevalence of vitamin B 12 deficiency in patients with thyroid diseases with s ubclin i cal hypothyroidism. 100 subjects divided into 50 patients with subclinical hypothyroidism (females) and 50 control subjects whose age and sex matched the patients were i n cluded in the study. The serum levels of vitamin B 12 , ferritin , TSH, free T 3 and free T 4 were estimated through electro chemiluminescence by a cobas e 411 analyzer fully automated to identify cases of SCH. while zinc and magnesium were estimated by semi-automated photometry . In SCH patients with t hyroid diseases , both free T 3 and T 4 levels were within the normal range, whereas TSH levels were in the range of 4.9 – 11.2 mIU / L . Significantly low levels of serum vitamin B 12 ferritin were found in cases of subclinical hypothyroidism ( P < 0.0001). Based on the results of our study , we conclude that there is a higher prevalence of deficiency in vitamin B 12 , serum zinc , serum magnesium and serum ferritin in SCH thyroid disorder patients . Hence we recommend routine laborat ory testing and early detection of vit a min B12 deficiancy would be useful in deciding appropriate management measures .References
Andrès, E., Serraj, K., Zhu, J., & Vermorken, A. J. M. (2013). The pathophysiology of elevated vitamin B12 in clinical practice. QJM, 106(6), 505–515.
Borawska, M., Markiewicz-Żukowska, R., Dziemianowicz, R., Socha, K., & Soroczyńska, J. (2012). Wpływ nawyków żywieniowych i palenia papierosów na stężenie cynku w surowicy krwi kobiet z chorobą Hashimoto [The influence of dietary habits and smoking on zinc level in serum of women with Hashimoto disease]. Bromatologia i Chemia Toksykologiczna, 45(3), 759–765 (in Polish).
Bushra, S. K., & Jamal, F. (2022). Study of mineral profile in patients with hypothyroidism. International Journal of Advanced Biochemistry Research, 6(1), 55–60.
Cinemre, H., Bilir, C., Gokosmanoglu, F., & Bahcebasi, T. (2009). Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: A randomized, double-blind, controlled study. The Journal of Clinical Endocrinology and Metabolism, 94(1), 151–156.
Damayanti, D., Jaceldo-Siegl, K., Beeson, W. L., Fraser, G., Oda, K., & Haddad, E. H. (2018). Foods and supplements associated with vitamin B12 biomarkers among vegetarian and non-vegetarian participants of the Adventist Health Study-2 (AHS-2) calibration study. Nutrients, 10(6), 722.
Das, C., Sahana, P., Sengupta, N., Giri, D., Roy, M., & Mukhopadhyay, P. (2012). Etiology of anemia in primary hypothyroid subjects in a tertiary care center in Eastern India. Indian Journal of Endocrinology and Metabolism, 16(8), 361.
Dobosz, P., Konopka, W., Cenda, P., Nazim-Zygadło, E., & Kozok, A. (2009). Wpływ tonsillektomii na stężenie cynku w surowicy krwi. Otolaryngologia Polska, 63(1), 16–18.
Esposito, G., Dottori, L., Pivetta, G., Ligato, I., Dilaghi, E., & Lahner, E. (2022). Pernicious anemia: The hematological presentation of a multifaceted disorder caused by cobalamin deficiency. Nutrients, 14(8), 1672.
Javed, Z., & Sathyapalan, T. (2016). Levothyroxine treatment of mild subclinical hypothyroidism: A review of potential risks and benefits. Therapeutic Advances in Endocrinology and Metabolism, 7(1), 12–23.
LeFevre, M. L. (2015). Screening for thyroid dysfunction: U.S. preventive services task force recommendation statement. Annals of Internal Medicine, 162(9), 641–650.
Mallick, D., Choudhury, J., Bhattacharya, A., & Bandyopadhyay, D. (2023). Study of serum iron and vitamin B12 status in primary hypothyroidism at a tertiary care hospital in eastern region of India. National Journal of Physiology, Pharmacy and Pharmacology, 13(10), 2130–2134.
Nexo, E., Christensen, A. L., Hvas, A. M., Petersen, T. E., & Fedosov, S. N. (2002). Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clinical Chemistry, 48(3), 561–562.
Shakir, K. M., Turton, D., Aprill, B. S., Drake, A. J., 3rd, & Eisold, J. F. (2000). Anemia: A cause of intolerance to thyroxine sodium. Mayo Clinic Proceedings, 75(2), 189–192.
Sinha, M. K., Sinha, M., & Usmani, F. (2022). A study of the correlation between vitamin B12, folic acid and ferritin with thyroid hormones in hypothyroidism. International Journal of Health Sciences, 6(S2), 6877–6884.
Szczepanek-Parulska, E., Hernik, A., & Ruchała, M. (2017). Anemia in thyroid diseases. Polish Archives of Internal Medicine, 127, 352–360.
Tripathi, P., Saxena, N., Verma, M. K., & Singh, A. N. (2019). Association of vitamin B12, folate and ferritin with thyroid hormones in hypothyroidism. Annals of International Medical and Dental Research, 5(1), 1–6.
Turanjanin, D., Mijovic, R., Starcevic, I., & Tatalovic, V. (2024). Calcium and magnesium levels in patients with primary hypothyroidism. Medical Review, 77(3–4), 106–112.
Yilmaz, S., Ozan, S., Benzer, F., & Canatan, H. (2003). Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell Biochemistry and Function, 21(4), 325–330.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.


